Marjorie Perloff - Publications

Affiliations: 
Stanford University, Palo Alto, CA 
Area:
Modern Literature, Comparative Literature, English Literature

3/139 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2006 Bennett PB, Davidson M, Dubrow H, DuPlessis RB, Harris WJ, Jones MD, Liu W, McGann J, Metres P, Nielsen AL, Noland C, Perloff M, Rubin JS, Spahr J, Wienen MWV, et al. Reading Lines Forum The Iowa Journal of Cultural Studies. 8: 111-159. DOI: 10.17077/2168-569X.1076  0.398
1993 McGann JJ, Chernetsky V, Dragomoshchenko A, Epshtein M, Hejinian L, Perelman B, Perloff M. Symposium on Russian Postmodernism Postmodern Culture. 3. DOI: 10.1353/Pmc.1993.0015  0.32
1993 Perloff M. Russian Postmodernism: An Oxymoron? Postmodern Culture. 3. DOI: 10.1353/Pmc.1993.0008  0.32
Low-probability matches (unlikely to be authored by this person)
2004 Perloff M. Differentials: Poetry, poetics, pedagogy Differentials: Poetry, Poetics, Pedagogy. 1-307.  0.273
2006 Perloff M. Can a contemporary poet write about the holocaust? Michigan Quarterly Review. 45: 336-340.  0.27
2010 Alexander S, Beer G, Boumelha P, DuPlessis RB, Evans M, Griffin G, Halberstam J, Jolly M, Kaplan C, Merck M, Patel P, Perloff M, Raitt S, Rees-Jones D, Rowbotham S, et al. Desert Island Texts Women: a Cultural Review. 21: 10-74. DOI: 10.1080/09574040903558420  0.262
2005 Perloff M. Reading modernism, after Hugh Kenner (1923-2003): Hugh Kenner and the invention of modernism Modernism - Modernity. 12: 465-469.  0.234
2005 Perloff M. The avant-garde phase of american modernism The Cambridge Companion to American Modernism. 195-218. DOI: 10.1017/CCOL052182995X.009  0.234
2011 Perloff M. Writing Philosophy as Poetry: Literary form in Wittgenstein The Oxford Handbook of Wittgenstein. DOI: 10.1093/oxfordhb/9780199287505.003.0032  0.232
2010 Perloff M. Language in migration: Multilingualism and exophonic writing in the new poetics Textual Practice. 24. DOI: 10.1080/0950236X.2010.499660  0.217
1998 Bouchard R, Perloff M, DellaRocca L, Harper LL, Groenewald D, Lite J. Selected Letters from Readers Postmodern Culture. 9. DOI: 10.1353/Pmc.1998.0042  0.215
2008 Kermode F, Perloff M. Modernism and Romanticism Modernism. 61-98. DOI: 10.1002/9780470690161.ch1  0.206
2004 Perloff M. The Oulipo factor: The procedural poetics of Christian Bok and Caroline Bergvall Textual Practice. 18: 23-45. DOI: 10.1080/0950236042000183250  0.205
2011 Perloff M. D. H. Lawrence The Cambridge Companion to English Poets. 475-490. DOI: 10.1017/CCOL9780521874342.027  0.202
2012 Perloff M. 'Easter, 1916': Yeats's First World War Poem The Oxford Handbook of British and Irish War Poetry. DOI: 10.1093/oxfordhb/9780199559602.013.0013  0.193
2012 Perloff M. Difference and discipline: The Cage/Cunningham aesthetic revisited Contemporary Music Review. 31: 19-35. DOI: 10.1080/07494467.2012.712281  0.187
2011 Perloff M. The avant-garde T. S. Eliot in Context. 252-262. DOI: 10.1017/CBO9780511973673.026  0.181
1997 Perloff M. A passion for content: Restoring 'literary literacy' to the english curriculum Chronicle of Higher Education. 43.  0.179
1999 Perloff M. Language poetry and the lyric subject: Ron Silliman's albany, Susan Howe's buffalo Critical Inquiry. 25: 405-434.  0.158
2014 Perloff M. Yeats and the occasional poem: "Easter 1916" Papers On Language and Literature. 50: 326-351.  0.156
2007 Perloff M. Read the poem Tls - the Times Literary Supplement. 22.  0.155
1991 Perloff M. Stit and the language of agency Synthese. 86: 379-408. DOI: 10.1007/BF00485267  0.153
1992 Perloff M. Great american novel? Anq - Quarterly Journal of Short Articles Notes and Reviews. 5: 229-231. DOI: 10.1080/0895769X.1992.10542778  0.149
2009 Perloff M. "The rattle of statistical traffic": citation and found text in susan howe's the midnight Boundary 2. 36: 205-228. DOI: 10.1215/01903659-2009-030  0.145
2009 Perloff M. Constraint, concrete, citation: Refiguring history in Charles Bernstein's Shadowtime Poetics Today. 30: 693-717. DOI: 10.1215/03335372-2009-010  0.144
2008 Perloff M. Constraint, concrete, citation: Refiguring history in Charles Bernstein' s Shadowtime Foreign Literature Studies. 2008.  0.144
2011 Perloff M. Whitman in the 21st century Europe. 89: 52-60.  0.142
2006 Perloff M. Avant-garde community and the individual talent: The case of language poetry Foreign Literature Studies. 2006.  0.142
2002 Perloff M. Pound/Stevens: Whose era? revisited Wallace Stevens Journal. 26: 135-142.  0.136
2012 Perloff M. Editorial Textual Practice. 26: 377. DOI: 10.1080/0950236X.2012.684938  0.134
2011 Perloff M. Beckett in the Country of the Houyhnhms: The transformation of Swiftian satire Samuel Beckett Today - Aujourd'Hui. 22: 17-38.  0.131
2014 Perloff M. Avant-garde in a different key: Karl Kraus's the last days of mankind Critical Inquiry. 40: 311-338. DOI: 10.1086/674117  0.123
2013 Perloff M. Take five Poetry. 202: 41-43.  0.12
2004 Perloff M. Chuff chuff chuff Tls - the Times Literary Supplement. 5-6.  0.12
2007 Perloff M. It must change. Presidential address, modern language association: December 2006 Poetry Review. 97: 50-64.  0.12
2005 Perloff M. Avant-garde tradition and individual talent: The case of language poetry Revue Francaise D'Etudes Americaines. 117-141.  0.112
1998 Perloff M. The poetics of description: Wittgenstein on the aesthetic Parallax. 4: 79-89. DOI: 10.1080/135346498250028  0.112
2004 Perloff M. The Vienna Paradox: Émigré Reinvention and the New World Western Humanities Review. 58: 40-73.  0.107
2003 Perloff M. Taking agents seriously Cybernetics and Systems. 34: 253-281. DOI: 10.1080/01969720390216177  0.106
1986 Perloff M, Killen JY, Wittes RE. Small cell bronchogenic carcinoma Current Problems in Cancer. 10: 169-214. PMID 3013505 DOI: 10.1016/S0147-0272(86)80015-0  0.101
2003 Perloff M. The search for "prime words": Pound, Duchamp and the nominalist ethos Paideuma. 2003: 205-228.  0.098
2000 Perloff M. "Multiple Pleats": Some applications of michel serres's poetics Configurations. 8: 187-200.  0.094
2005 Perloff M. The Great War and the European avant-garde The Cambridge Companion to the Literature of the First World War. 141-165. DOI: 10.1017/CCOL0521821452.007  0.093
1993 Belnap N, Perloff M. In the realm of agents Annals of Mathematics and Artificial Intelligence. 9: 25-48. DOI: 10.1007/Bf01531260  0.088
1977 Perloff M, Holland JF, Lumb GJ, Bekesi JG. Effects of Methanol Extraction Residue of Bacillus Calmette-Guérin in Humans Cancer Research. 37: 1191-1196. PMID 321117  0.087
2017 Marshall JR, Burk RF, Ondracek RP, Hill KE, Perloff M, Davis W, Pili R, George S, Bergan R. Selenomethionine and methyl selenocysteine: multiple-dose pharmacokinetics in selenium-replete men. Oncotarget. PMID 28412747 DOI: 10.18632/Oncotarget.15460  0.087
2011 Marshall JR, Ip C, Romano K, Fetterly G, Fakih M, Jovanovic B, Perloff M, Crowell J, Davis W, French-Christy R, Dew A, Coomes M, Bergan R. Methyl selenocysteine: single-dose pharmacokinetics in men. Cancer Prevention Research (Philadelphia, Pa.). 4: 1938-44. PMID 21846796 DOI: 10.1158/1940-6207.Capr-10-0259  0.086
1982 Perloff M, Lesnick GJ. Chemotherapy Before and After Mastectomy in Stage III Breast Cancer Archives of Surgery. 117: 879-881. PMID 7092538 DOI: 10.1001/archsurg.1982.01380310005002  0.082
2013 Armstrong WB, Taylor TH, Kennedy AR, Melrose RJ, Messadi DV, Gu M, Le AD, Perloff M, Civantos F, Goodwin WJ, Wirth LJ, Kerr AR, Meyskens FL. Bowman birk inhibitor concentrate and oral leukoplakia: a randomized phase IIb trial. Cancer Prevention Research (Philadelphia, Pa.). 6: 410-8. PMID 23639862 DOI: 10.1158/1940-6207.Capr-13-0004  0.08
1981 Hart RD, Perloff M, Holland JF. One-day VATH (vinblastine, adriamycin, thiotepa, and halotestin) therapy for advanced breast cancer refractory to chemotherapy Cancer. 48: 1522-1527. PMID 6793224  0.078
1974 Perloff M, Muggia FM, Ackerman C. Role of a nitrosourea (CCNU, NSC-79037) in advanced nonhematologic cancer. Cancer Chemotherapy Reports. Part 1. 58: 421-4. PMID 4841718  0.078
2004 Perloff M. Stevens' collected poems in 2054 Wallace Stevens Journal. 28: 242-246.  0.074
2022 Thomas PS, Patel AB, Lee JJ, Liu DD, Hernandez M, Muzzio M, Contreras A, Sepeda V, Mays C, Weber D, Vornik LA, Khan SA, Dimond E, Heckman-Stoddard BM, Perloff M, et al. Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer. Cancer Prevention Research (Philadelphia, Pa.). PMID 36228112 DOI: 10.1158/1940-6207.CAPR-22-0210  0.073
2014 Perloff M. Studying literature in the '60s American Book Review. 35: 5+11. DOI: 10.1353/abr.2014.0076  0.073
2015 Lopez AM, Pruthi S, Boughey JC, Perloff M, Hsu CH, Lang JE, Ley M, Frank D, Taverna JA, Chow HS. Double-blind, Randomized Trial of Alternative Letrozole Dosing Regimens in Postmenopausal Women with Increased Breast Cancer Risk. Cancer Prevention Research (Philadelphia, Pa.). PMID 26667449 DOI: 10.1158/1940-6207.Capr-15-0322  0.072
1976 Perloff MM. Drug product quality--views of the practitioners. A physician's perception of quality Journal of the American Pharmaceutical Association. 16: 608-609. PMID 977887  0.07
2013 Perloff M, Steele VE. Early-phase development of cancer prevention agents: challenges and opportunities. Cancer Prevention Research (Philadelphia, Pa.). 6: 379-83. PMID 23466485 DOI: 10.1158/1940-6207.CAPR-12-0463  0.069
1981 Aisner J, Weinberg V, Perloff M. Chemoimmunotherapy for advanced breast cancer: A randomized comparison of 6 combinations (CMF, CAF vs CAFVP) each with or without MER immunotherapy. A CALGB study Proceedings of the American Association For Cancer Research 0.068
2024 Lee O, Bazzi LA, Xu Y, Pearson E, Wang M, Hosseini O, Akasha AM, Choi JN, Karlan S, Pilewskie M, Kocherginsky M, Benante K, Helland T, Mellgren G, Dimond E, ... Perloff M, et al. A randomized Phase I pre-operative window trial of transdermal endoxifen in women planning mastectomy: Evaluation of dermal safety, intra-mammary drug distribution, and biologic effects. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 171: 116105. PMID 38171245 DOI: 10.1016/j.biopha.2023.116105  0.067
1981 Orsini JM, Perloff M, Rybak B. Cystosarcoma phylloides: A case presentation Medical and Pediatric Oncology. 9: 449-453. PMID 6272077  0.067
2006 Perloff M. Between verse and prose: Beckett and the new poetry On Beckett: Essays and Criticism. 138-151. DOI: 10.7135/UPO9780857285805.014  0.066
2011 Perloff M, Belnap N. Future contingents and the battle tomorrow Review of Metaphysics. 64: 581-602.  0.066
2013 Perloff M. Meditations in an emergency Poetry. 201: 541-543.  0.065
2003 Malone W, Perloff M, Crowell J, Sigman C, Higley H. Fenretinide: a prototype cancer prevention drug. Expert Opinion On Investigational Drugs. 12: 1829-42. PMID 14585058 DOI: 10.1517/13543784.12.11.1829  0.064
1979 Perloff M. A better alternative Analysis (United Kingdom). 39: 106-108. DOI: 10.1093/analys/39.2.106  0.064
1975 Coleman JL, Perloff M. On the purported inconsistency of act-utilitarianism Philosophical Studies. 28: 297-298. DOI: 10.1007/BF00353979  0.064
2004 Perloff M. Translating Brazilian concrete poetry: The French connection Western Humanities Review. 58.  0.063
1978 Perloff M, Hart RD, Holland JF. Vinblastine, adriamycin, thiotepa, and halotestin (VATH). Therapy for advanced breast cancer refractory to prior chemotherapy Cancer. 42: 2534-2537. PMID 103610  0.063
2020 Reyes-Uribe L, Wu W, Gelincik O, Bommi PV, Francisco-Cruz A, Solis LM, Lynch PM, Lim R, Stoffel EM, Kanth P, Samadder NJ, Mork ME, Taggart MW, Milne GL, Marnett LJ, ... ... Perloff M, et al. Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa. Gut. PMID 32641470 DOI: 10.1136/Gutjnl-2020-320946  0.063
1975 Perloff M, Roboz J, Holland JF. Phase I study of ribavirin Proceedings of the American Association For Cancer Research. 16.  0.061
2016 Mullooly M, Pfeiffer RM, Heckman-Stoddard BM, Perloff M, Brinton LA, Hoover RN, Berrington de Gonzalez A, Sherman ME, Gierach GL, Nyante SJ, Jatoi I, Aiello Bowles EJ, Glass A. Mammographic Density as a Biosensor of Tamoxifen Effectiveness in Adjuvant Endocrine Treatment of Breast Cancer: Opportunities and Implications. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27022110 DOI: 10.1200/Jco.2015.64.4492  0.061
1998 Beinfeld MC, Perloff MD, Venkatakrishnan K. Identification of glycine-extended CCK peptides in endocrine cells and modulation of CCK amide and CCK Gly content and secretion from endocrine tumor cells by an inhibitor of amidation Peptides. 19: 1393-1398. PMID 9809654 DOI: 10.1016/S0196-9781(98)00098-9  0.061
2010 Perloff M. Poets who teach Tls - the Times Literary Supplement. 6.  0.06
1992 Belnap N, Perloff M. The way of the agent Studia Logica. 51: 463-484. DOI: 10.1007/Bf01028971  0.059
2015 Joe AK, Schnoll-Sussman F, Bresalier RS, Abrams JA, Hibshoosh HH, Cheung YK, Friedman RA, Yang CS, Milne GL, Liu D, Lee JJ, Abdul K, Bigg M, Foreman JT, Su T, ... ... Perloff M, et al. Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients with Barrett's Esophagus. Cancer Prevention Research (Philadelphia, Pa.). PMID 26471236 DOI: 10.1158/1940-6207.Capr-14-0274-T  0.059
1979 Vogl SE, Perloff M, Kaplan BH, Holland JF. Phase I study of iv administration of methanol extraction residue of bacillus Calmette-Guerin Cancer Treatment Reports. 63: 2039-2041. PMID 393387  0.058
2011 Reid JM, Walden CA, Qin R, Ziegler KL, Haslam JL, Rajewski RA, Warndahl R, Fitting CL, Boring D, Szabo E, Crowell J, Perloff M, Jong L, Bauer BA, Mandrekar SJ, et al. Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668. Cancer Prevention Research (Philadelphia, Pa.). 4: 347-53. PMID 21372034 DOI: 10.1158/1940-6207.Capr-10-0313  0.057
1977 Perloff M, Holland JF. Surgical adjuvant chemotherapy Annual Review of Medicine. 28: 475-488. PMID 193434  0.056
2003 Perloff M. Seductive Vienna Modernism - Modernity. 10: 221-238.  0.055
1978 Tormey D, Leone L, Perloff M, Bloomfield C. Evaluation of intermittent vs continuous and of adriamycin vs methotrexate 5-drug chemotherapy regimens for breast cancer Proceedings of the American Association For Cancer Research 0.054
2020 Lee O, Pilewskie M, Karlan S, Tull MB, Benante K, Xu Y, Blanco L, Helenowski I, Kocherginsky M, Yadav S, Hosseini O, Hansen N, Bethke K, Muzzio M, Troester MA, ... ... Perloff M, et al. Local transdermal delivery of telapristone acetate through breast skin, compared to oral treatment: a randomized double-blind, placebo-controlled Phase II trial. Clinical Pharmacology and Therapeutics. PMID 32996592 DOI: 10.1002/cpt.2041  0.053
2015 Berlin RK, Butler PM, Perloff MD. Gabapentin therapy in psychiatric disorders: A systematic review Primary Care Companion to the Journal of Clinical Psychiatry. 17: 330. DOI: 10.4088/PCC.15r01821  0.052
1976 Vogl S, Ohnuma T, Perloff M, Holland JF. Combination chemotherapy with adriamycin and cis diamminedichloroplatinum in patients with neoplastic diseases Cancer. 38: 21-26. PMID 985619  0.052
2015 Perloff MD. Practical considerations in opioid use for brain neoplasm Continuum (Minneapolis, Minn.). 21: 480-486. PMID 25837908 DOI: 10.1212/01.CON.0000464183.35322.5f  0.051
2005 Kelley MJ, Glaser EM, Herndon JE, Becker F, Bhagat R, Zhang YJ, Santella RM, Carmella SG, Hecht SS, Gallot L, Schilder L, Crowell JA, Perloff M, Folz RJ, Bergan RC. Safety and efficacy of weekly oral oltipraz in chronic smokers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 892-9. PMID 15824161 DOI: 10.1158/1055-9965.Epi-04-0585  0.05
1980 Perloff M, Lesnick GJ. Avascular necrosis of the femoral head: Association with adjuvant chemotherapy for breast carcinoma Cancer Treatment Reports. 64: 361-362. PMID 7407772  0.05
1976 Perloff M, Holland JF, Bekesi JG. Chemoimmunotherapy of breast cancer Proceedings of the American Association For Cancer Research 0.048
2011 Bishayee A, Ahmed S, Brankov N, Perloff M. Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer. Frontiers in Bioscience (Landmark Edition). 16: 980-96. PMID 21196213 DOI: 10.2741/3730  0.047
1971 Perloff MM. Anti-substitution law repeal--pro and con: the case against repeal American Journal of Pharmacy and the Sciences Supporting Public Health. 143: 15-23. PMID 5162747  0.046
1982 Perloff M, Norton L, Mass T. Intensive six-week courses of combination chemotherapy in stage IV breast carcinoma Proceedings of the American Society of Clinical Oncology 0.045
2023 Khan SA, Mi X, Xu Y, Blanco LZ, Akasha AM, Pilewskie M, Degnim AC, AlHilli Z, Amin AL, Hwang ES, Guenther JM, Kocherginsky M, Benante K, Zhang S, Helland T, ... ... Perloff M, et al. Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ: A Randomized Clinical Trial. Jama Surgery. PMID 37870954 DOI: 10.1001/jamasurg.2023.5113  0.045
1986 Friedman MA, Dorr FA, Perloff M. Adjuvant therapy for breast cancer patients with negative lymph nodes Nci Monographs. 139-144. PMID 3534587  0.045
2002 Beenken SW, Hockett R, Grizzle W, Weiss HL, Pickens A, Perloff M, Malone WF, Bland KI. Transforming growth factor-alpha: a surrogate endpoint biomarker? Journal of the American College of Surgeons. 195: 149-58. PMID 12168960 DOI: 10.1016/S1072-7515(02)01219-X  0.044
1985 de Pedro H, Planeta S, Perloff M. MULTIMEDIA NETWORKING TECHNIQUES TO ENHANCE COMMUNICATIONS SURVIVABILITY Proceedings - Ieee Military Communications Conference. 308-312.  0.044
2010 Chow HH, Garland LL, Hsu CH, Vining DR, Chew WM, Miller JA, Perloff M, Crowell JA, Alberts DS. Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study. Cancer Prevention Research (Philadelphia, Pa.). 3: 1168-75. PMID 20716633 DOI: 10.1158/1940-6207.Capr-09-0155  0.044
2007 Boocock DJ, Faust GE, Patel KR, Schinas AM, Brown VA, Ducharme MP, Booth TD, Crowell JA, Perloff M, Gescher AJ, Steward WP, Brenner DE. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 1246-52. PMID 17548692 DOI: 10.1158/1055-9965.EPI-07-0022  0.043
1988 Greenspan EM, Perloff M, Tannock I. Treating the patient, not just the cancer New England Journal of Medicine. 318: 1472-1473. PMID 2452985  0.043
2023 Bowen CM, Deng N, Reyes-Uribe L, Parra ER, Rocha P, Solis LM, Wistuba II, Sepeda VO, Vornik L, Perloff M, Szabo E, Umar A, Sinha KM, Brown PH, Vilar E. Naproxen chemoprevention induces proliferation of cytotoxic lymphocytes in Lynch Syndrome colorectal mucosa. Frontiers in Immunology. 14: 1162669. PMID 37207208 DOI: 10.3389/fimmu.2023.1162669  0.043
1979 Perloff M, Norton L, Holland JF. Treatment of advanced breast cancer with a novel cyclophosphamide (C), methotrexate (M), 5-fluorouracil (F), vincristine (V) and prednisone (P) regimen Proceedings of the American Association For Cancer Research 0.043
1978 Gattanell PN, Perloff M, Holland JF. Hepatocellular carcinoma in a young woman with prolonged exposure to oral contraceptives Medical and Pediatric Oncology. 4: 99-103. PMID 207962  0.042
2012 Perloff M. I remember vanilla pudding Tls - the Times Literary Supplement. 10-11.  0.036
2010 Patel KR, Brown VA, Jones DJ, Britton RG, Hemingway D, Miller AS, West KP, Booth TD, Perloff M, Crowell JA, Brenner DE, Steward WP, Gescher AJ, Brown K. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Research. 70: 7392-9. PMID 20841478 DOI: 10.1158/0008-5472.CAN-10-2027  0.036
1978 Vogl SE, Perloff M, Holland JF, Bekesi JG. Phase I trial of intravenous (IV) administration of the methanol extraction residue of bacillus Calmette-Guerin (MER) Proceedings of the American Association For Cancer Research 0.036
2010 Brown VA, Patel KR, Viskaduraki M, Crowell JA, Perloff M, Booth TD, Vasilinin G, Sen A, Schinas AM, Piccirilli G, Brown K, Steward WP, Gescher AJ, Brenner DE. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Research. 70: 9003-11. PMID 20935227 DOI: 10.1158/0008-5472.Can-10-2364  0.035
2015 Perloff M. Ezra pound and Olga rudge Tls - the Times Literary Supplement. 6.  0.035
2006 Perloff M. Force fed with little portions Tls - the Times Literary Supplement. 10-11.  0.034
2008 Perloff M, Dworkin C. The sound of poetry / the poetry of sound: The 2006 MLA presidential forum Pmla. 123: 749. DOI: 10.1632/pmla.2008.123.3.749  0.034
2004 Perloff M. Don't mention the war Tls - the Times Literary Supplement. 12-13.  0.033
1977 Perloff M, Holland JF, Bushkin E. Adriamycin(ADM), vinblastine(VLB), thiotepa(TT) and fluoxymesterone (F) in stage IV breast carcinoma Proceedings of the American Association For Cancer Research 0.032
1968 Daniel TM, Perloff M, Major JJ, Baum GL. The demonstration of antibodies to para-aminosalicylic acid in human serum The Journal of Laboratory and Clinical Medicine. 72: 239-244. PMID 4174908  0.031
2004 Perloff JK, Perloff M. Coronary artery bypass: a user's manual. The American Journal of Cardiology. 94: 172-7. PMID 15246894 DOI: 10.1016/j.amjcard.2004.03.056  0.03
2010 Perloff MD, Leroy AM, Ensrud ER. Teaching Video NeuroImages: The elusive L5 reflex Neurology. 75. PMID 20837959 DOI: 10.1212/WNL.0b013e3181f25ea6  0.029
1998 Autran J, Frégier M, Perloff M. SIG, graphique et projet urbain Mappemonde. 49: 40-43.  0.028
2003 Perloff M. The return of Robert Lowell Parnassus. 27: 99-102.  0.028
2003 Perloff M. Man with a red and green tie Tls - the Times Literary Supplement. 8-9.  0.028
1976 Ribner B, Keusch GT, Hanna BA, Perloff M. Combination amphotericin B rifampin therapy for pulmonary aspergillosis in a leukemic patient Chest. 70: 681-683. PMID 789031  0.027
1975 Perloff M, Muggia FM. Carcinoma of thyroid gland. Associated with systemic amyloidosis and nephrotic syndrome New York State Journal of Medicine. 75: 1770-1771. PMID 1059903  0.027
1978 Perloff M, Bushkin E, Holland JF, Dorph D. Dose response curves during intradermal immunotherapy Proceedings of the American Association For Cancer Research 0.026
2003 Decensi A, Veronesi U, Miceli R, Johansson H, Mariani L, Camerini T, Di Mauro MG, Cavadini E, De Palo G, Costa A, Perloff M, Malone WF, Formelli F. Relationships between plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3 and second breast cancer risk in a prevention trial of fenretinide. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 4722-9. PMID 14581342  0.025
1973 Perloff MM, Spiegelman J. Hypnosis in the Treatment of a Child’s Allergy to Dogs American Journal of Clinical Hypnosis. 15: 269-272. PMID 4798439 DOI: 10.1080/00029157.1973.10402261  0.025
1998 Perloff MD, Kream RM, Beinfeld MC. Reduced levels of substance P in the brains of Cpe(fat)/Cpe(fat) mice Peptides. 19: 1115-1117. PMID 9700764 DOI: 10.1016/S0196-9781(98)00010-2  0.024
1969 Case WG, Perloff M, Vlachos VA, Rickels K. Side reactions in neurotic patients treated with Bristol CM-6 Current Therapeutic Research - Clinical and Experimental. 11: 77-79. PMID 4975817  0.022
2012 Rayhill ML, Perloff MD. Gabapentin use in the prevention of succinylcholine-induced fasciculation and myalgia Journal of Postgraduate Medicine. 58: 1-2. PMID 22387640 DOI: 10.4103/0022-3859.93244  0.02
1961 LEVICK LJ, PERLOFF MM. Use of muscle-relaxing tranquilizer in ambulatory patients Clinical Medicine. 8: 2147-2149. PMID 15445811  0.019
1976 Glantz SA, Luetscher JA, Day RP, Perloff M. A Compartment Description for Cortisol Secretion, Distribution, Binding, and Metabolism in Man Ieee Transactions On Biomedical Engineering. 36-44. PMID 172432 DOI: 10.1109/TBME.1976.324613  0.018
2003 Perloff M. A response to Ronald Schuchard Modernism - Modernity. 10: 51-56.  0.017
1976 Perloff M, Holland JF. Chemotherapeutic management and assessment of response International Journal of Radiation Oncology, Biology, Physics. 1: 535-538. PMID 972115 DOI: 10.1016/0360-3016(76)90025-0  0.015
1954 Perloff MM. Congenital dermal sinus complicated by meningitis. Report of a case The Journal of Pediatrics. 44: 73-76. PMID 13131200  0.014
2002 Perloff M. A survivor Tls - the Times Literary Supplement. 5-6.  0.014
1977 Perloff M, Ohnuma T, Holland JF. Adriamycin (ADM) and diamminedichloroplatinum (DDP) in advanced prostatic carcinoma (PC) Proceedings of the American Association For Cancer Research 0.014
2000 Mehra RK, Perloff M. Empirical methods for call admission control Proceedings of the Ieee Conference On Decision and Control. 2: 1439-1444.  0.011
2015 Perloff MD, Lee S. 25% Cluster Cephalalgia. 35: 635. DOI: 10.1177/0333102414544981  0.01
2015 Savino AK, Perloff MD. Epidural glucocorticoid injections for spinal stenosis, Interlaminal at the worst level Pain Medicine (United States). DOI: 10.1111/pme.12901  0.01
2014 Zhu S, Perloff MD. TIA for the internist American Journal of Medicine. 127: 901-902. PMID 24997414 DOI: 10.1016/j.amjmed.2014.06.024  0.01
2014 Perloff M. You've got mail Tls - the Times Literary Supplement. 5.  0.01
2011 Perloff M. Beyond "adagia": Eccentric design in Stevens' poetry Wallace Stevens Journal. 35: 16-32. DOI: 10.1353/wsj.2011.0011  0.01
2011 Perloff M. The absurdist roar missing from a filmed Howl: Holy, holy, holy hyperbole! Tls - the Times Literary Supplement. 17-18.  0.01
2008 Perloff M. At home with terror Tls - the Times Literary Supplement. 3-4.  0.01
1982 Perloff M. Learning from nursing Nursing. 12: 12.  0.01
Hide low-probability matches.